Sumitomo Dainippon Pharma Co ( (JP:4506)) has issued an announcement. Sumitomo Pharma Co., Ltd. has announced an extension of reduced remuneration for its directors due to ongoing financial ...

Vivek Ramaswamy’s Roivant group has forged its biggest and most wide-ranging alliance to date, licensing dozens of drugs to Japan’s Sumitomo Dainippon Pharma in deal that includes a massive $3 ...

In a report released on April 4, Stephen Barker from Jefferies maintained a Buy rating on Sumitomo Dainippon Pharma Co (DNPUF – Research Report), with a price target of Yen1,100.00. The company ...

Six weeks after Sumitomo Dainippon Pharma agreed a $3 billion deal to license a host of drug candidates developed by companies in Vivek Ramaswamy’s Roivant group, the detail of the transaction ...

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Olympus (OCPNF – Research Report) and Corvus ...

About Sumitomo Pharma Co. Ltd. Sumitomo Pharma Co., Ltd. engages in manufacture, sale, import, and export of pharmaceutical products. It operates through the Pharmaceutical Business and Other ...